Cargando…

Understanding risk and refining surveillance following tumor resection for low grade non-muscle invasive bladder cancer

Detalles Bibliográficos
Autores principales:	Peyton, Charles C., Azizi, Mounsif, Sexton, Wade J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256040/ https://www.ncbi.nlm.nih.gov/pubmed/30505739 http://dx.doi.org/10.21037/tau.2018.07.07

Ejemplares similares

Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial
por: Azawi, Nessn, et al.
Publicado: (2023)

Active surveillance for non-muscle invasive bladder cancer
por: Marcq, Gautier, et al.
Publicado: (2019)

The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer
por: Vasdev, Nikhil, et al.
Publicado: (2012)

Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?
por: Hurle, Rodolfo, et al.
Publicado: (2020)

Microscopic hematuria and pelvic ultrasonography could rule out flexible cystoscopy during surveillance for T1-low grade non-muscle invasive bladder cancer
por: Awad, Mohamed, et al.
Publicado: (2023)

Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA
por: Barocas, Daniel A., et al.
Publicado: (2012)

Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer
por: Herr, Harry W.
Publicado: (2011)

Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non–Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013
por: Bree, Kelly K., et al.
Publicado: (2022)

Implications of Programmed Death Ligand-1 Positivity in Non-Clear Cell Renal Cell Carcinoma
por: Chipollini, Juan, et al.
Publicado: (2018)

Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets
por: Chipollini, Juan, et al.
Publicado: (2017)

Where are we with bladder preservation for muscle-invasive bladder cancer in 2017?
por: Smelser, Woodson Wade, et al.
Publicado: (2017)

The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer
por: Russell, Christopher M., et al.
Publicado: (2016)

Prognostic Implications of Deep Muscle Invasion and High Grade for Bladder Urothelial Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2020)

Multivariate Analysis of the Prognostic Significance of Resection Weight after Transurethral Resection of Bladder Tumor for Non-Muscle-Invasive Bladder Cancer
por: Kwon, Dae Hyeon, et al.
Publicado: (2012)

Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer
por: Fujita, Naoki, et al.
Publicado: (2022)

Neoadjuvant versus Adjuvant Chemotherapy in Patients with Resectable Muscle-Invasive Bladder Cancer
por: Sawasdee, Anupong, et al.
Publicado: (2022)

Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
por: Liu, Zheng, et al.
Publicado: (2021)

The Clinical Impact of Tumor Grade Heterogeneity in Non-muscle-invasive Urothelial Carcinoma of the Bladder
por: CULPAN, Meftun, et al.
Publicado: (2021)

Recurrence of Subepithelial Non-Muscle Invasive Bladder Cancer Following Transurethral Resection: A Case Report
Publicado: (2021)

Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer
por: Heijnsdijk, Eveline A.M., et al.
Publicado: (2018)

Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression
por: Kobayashi, Hiroaki, et al.
Publicado: (2014)

High-Grade Non-Muscle Invasive Bladder Cancer: When to Move to Early Radical Cystectomy?
por: Azhar, Raed A, et al.
Publicado: (2021)

Oncological outcomes of high-grade T1 non-muscle-invasive bladder cancer treatment in octogenarians
por: Ślusarczyk, Aleksander, et al.
Publicado: (2021)

An MRI-based radiomics nomogram in predicting histologic grade of non-muscle-invasive bladder cancer
por: Li, Longchao, et al.
Publicado: (2023)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Current and Innovative Approaches in the Treatment of Non-muscle Invasive Bladder Cancer: The Role of Transurethral Resection of Bladder Tumor and Organoids
por: Taskovska, Milena, et al.
Publicado: (2020)

Prostatic urethra recurrence after transurethral resection of bladder tumor (TURBT) for non‐muscle‐invasive bladder cancer (NMIBC)
por: Bilim, Vladimir, et al.
Publicado: (2022)

Challenging dilemmas of low grade, non-invasive bladder cancer: a narrative review
por: Korkes, Fernando, et al.
Publicado: (2021)

Identifying the Molecular Mechanisms Contributing to Progression, Metastasis, and Death in Low-grade Non–muscle-invasive Bladder Cancer: A Case Report
por: Weiß, Sarah, et al.
Publicado: (2021)

Active surveillance for nonmuscle invasive bladder cancer
por: Miyake, Makito, et al.
Publicado: (2016)

An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
por: Soria, Francesco, et al.
Publicado: (2018)

Molecular characterization of low grade and high grade bladder cancer
por: Apollo, Alessandro, et al.
Publicado: (2019)

Prognostic nomogram for estimating survival in patients with resected muscle-invasive bladder cancer receiving chemotherapy
por: Hu, Bing, et al.
Publicado: (2023)

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer
por: Kusaka, Ayumu, et al.
Publicado: (2017)

Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer—A Pilot Study
por: Chai, C. A., et al.
Publicado: (2021)

A refined procedure for esophageal resection using a full minimally invasive approach
por: Ashiku, Simon K., et al.
Publicado: (2022)

The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer
por: Soria, Francesco, et al.
Publicado: (2019)

Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2017)

Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer
por: Gill, Tejpal S., et al.
Publicado: (2014)

Systematic Review and Meta-Analysis on the Efficacy of Chemotherapy with Transurethral Resection of Bladder Tumors as Definitive Therapy for Muscle Invasive Bladder Cancer
por: Moran, George W., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b063urrgfn5t42er5dokb49rd3